Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.
Faycal A, Ndoadoumgue AL, Sellem B, Blanc C, Dudoit Y, Schneider L, Tubiana R, Valantin MA, Seang S, Palich R, Bleibtreu A, Monsel G, Godefroy N, Itani O, Paccoud O, Pourcher V, Caumes E, Ktorza N, Chermak A, Abdi B, Assoumou L, Katlama C; COVIDOM-19 PSL research group. Faycal A, et al. Among authors: assoumou l. Infect Dis Now. 2022 Mar;52(2):75-81. doi: 10.1016/j.idnow.2021.11.003. Epub 2021 Nov 17. Infect Dis Now. 2022. PMID: 34800742 Free PMC article.
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.
Schneider L, Ktorza N, Fourati S, Assoumou L, Courbon E, Caby F, Blanc C, Tindel M, Agher R, Marcelin AG, Calvez V, Peytavin G, Katlama C. Schneider L, et al. Among authors: assoumou l. HIV Clin Trials. 2012 Sep-Oct;13(5):284-8. doi: 10.1310/hct1305-284. HIV Clin Trials. 2012. PMID: 23134629 Clinical Trial.
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).
Soulié C, Assoumou L, Darty M, Rodriguez C, Donati F, Sayon S, Peytavin G, Valantin MA, Caby F, Schneider L, Canestri A, Costagliola D, Katlama C, Calvez V, Marcelin AG; ROCnRAL ANRS-157 Study Group. Soulié C, et al. Among authors: assoumou l. J Antimicrob Chemother. 2015 Dec;70(12):3339-44. doi: 10.1093/jac/dkv280. Epub 2015 Sep 22. J Antimicrob Chemother. 2015. PMID: 26396157 Clinical Trial.
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.
Desnoyer A, Dupin N, Assoumou L, Carlotti A, Gaudin F, Deback C, Peytavin G, Marcelin AG, Boué F, Balabanian K, Pourcher V; ANRS 154 LENAKAP trial group. Desnoyer A, et al. Among authors: assoumou l. Br J Dermatol. 2016 Dec;175(6):1251-1262. doi: 10.1111/bjd.14748. Epub 2016 Oct 12. Br J Dermatol. 2016. PMID: 27177037 Clinical Trial.
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
Pourcher V, Desnoyer A, Assoumou L, Lebbe C, Curjol A, Marcelin AG, Cardon F, Gibowski S, Salmon D, Chennebault JM, Poizot-Martin I, Peytavin G, Boué F, Costagliola D. Pourcher V, et al. Among authors: assoumou l. AIDS Res Hum Retroviruses. 2017 Jan;33(1):1-10. doi: 10.1089/AID.2016.0069. Epub 2016 Sep 7. AIDS Res Hum Retroviruses. 2017. PMID: 27405442 Clinical Trial.
126 results